{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:22:36Z","timestamp":1792790556492,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000051","name":"U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute","doi-asserted-by":"publisher","award":["R35GM118062"],"award-info":[{"award-number":["R35GM118062"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/00baak391","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000051","name":"U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute","doi-asserted-by":"publisher","award":["RM1HG009490"],"award-info":[{"award-number":["RM1HG009490"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/00baak391","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute","id":[{"id":"https:\/\/ror.org\/00baak391","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mutations in\n                    <jats:italic>Atp2b2<\/jats:italic>\n                    , an outer hair cell gene, cause dominant hearing loss in humans. Using a mouse model\n                    <jats:italic>Atp2b2<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>Obl<\/jats:italic>\n                      \/+\n                    <\/jats:sup>\n                    , with a dominant hearing loss mutation (Oblivion), we show that liposome-mediated in vivo delivery of CRISPR-Cas9 ribonucleoprotein complexes leads to specific editing of the\n                    <jats:italic>Obl<\/jats:italic>\n                    allele. Large deletions encompassing the\n                    <jats:italic>Obl<\/jats:italic>\n                    locus and indels were identified as the result of editing. In vivo genome editing promotes outer hair cell survival and restores their function, leading to hearing recovery. We further show that in a double-dominant mutant mouse model, in which the\n                    <jats:italic>Tmc1<\/jats:italic>\n                    Beethoven mutation and the\n                    <jats:italic>Atp2b2<\/jats:italic>\n                    Oblivion mutation cause digenic genetic hearing loss, Cas9\/sgRNA delivery targeting both mutations leads to partial hearing recovery. These findings suggest that liposome-RNP delivery can be used as a strategy to recover hearing with dominant mutations in OHC genes and with digenic mutations in the auditory hair cells, potentially expanding therapeutics of gene editing to treat hearing loss.\n                  <\/jats:p>","DOI":"10.1038\/s41467-023-40476-7","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T10:02:19Z","timestamp":1692093739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo"],"prefix":"10.1038","volume":"14","author":[{"given":"Yong","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Lamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenliang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3382-1134","authenticated-orcid":false,"given":"Madelynn N.","family":"Whittaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Zuris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8599-569X","authenticated-orcid":false,"given":"Arun Prabhu","family":"Rameshbabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8893-434X","authenticated-orcid":false,"given":"Yilai","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3213-9704","authenticated-orcid":false,"given":"Xue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny H.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5410-2297","authenticated-orcid":false,"given":"Wei-Jia","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5469-0655","authenticated-orcid":false,"given":"Benjamin P.","family":"Kleinstiver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1452-4193","authenticated-orcid":false,"given":"Zheng-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,15]]},"reference":[{"key":"40476_CR1","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1002\/ar.22579","volume":"295","author":"S Angeli","year":"2012","unstructured":"Angeli, S., Lin, X. & Liu, X. Z. Genetics of hearing and deafness. Anat. Rec. 295, 1812\u20131829 (2012).","journal-title":"Anat. Rec."},{"key":"40476_CR2","doi-asserted-by":"publisher","first-page":"1241062","DOI":"10.1126\/science.1241062","volume":"344","author":"GS G\u00e9l\u00e9oc","year":"2014","unstructured":"G\u00e9l\u00e9oc, G. S. & Holt, J. R. Sound strategies for hearing restoration. Science 344, 1241062 (2014).","journal-title":"Science"},{"key":"40476_CR3","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrd4533","volume":"14","author":"U M\u00fcller","year":"2015","unstructured":"M\u00fcller, U. & Barr-Gillespie, P. G. New treatment options for hearing loss. Nat. Rev. Drug Discov. 14, 346\u2013365 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"40476_CR4","doi-asserted-by":"publisher","first-page":"295ra108","DOI":"10.1126\/scitranslmed.aab1996","volume":"7","author":"C Askew","year":"2015","unstructured":"Askew, C. et al. Tmc gene therapy restores auditory function in deaf mice. Sci. Transl. Med. 7, 295ra108 (2015).","journal-title":"Sci. Transl. Med."},{"key":"40476_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08264-w","volume":"10","author":"CA Nist-Lund","year":"2019","unstructured":"Nist-Lund, C. A. et al. Improved TMC1 gene therapy restores hearing and balance in mice with genetic inner ear disorders. Nat. Commun. 10, 236 (2019).","journal-title":"Nat. Commun."},{"key":"40476_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10162-017-0640-x","volume":"19","author":"A Ponnath","year":"2018","unstructured":"Ponnath, A. et al. Rescue of outer hair cells with antisense oligonucleotides in usher mice is dependent on age of treatment. J. Assoc. Res. Otolaryngol. 19, 1\u201316 (2018).","journal-title":"J. Assoc. Res. Otolaryngol."},{"key":"40476_CR7","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.ajhg.2016.03.028","volume":"98","author":"SB Shibata","year":"2016","unstructured":"Shibata, S. B. et al. RNA interference prevents autosomal-dominant hearing loss. Am. J. Hum. Genet. 98, 1101\u20131113 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"40476_CR8","doi-asserted-by":"publisher","unstructured":"Du, W. et al. Rescue of auditory function by a single administration of AAV-TMPRSS3 gene therapy in aged mice of human recessive deafness DFNB8. Mol. Ther. https:\/\/doi.org\/10.1016\/j.ymthe.2023.05.005 (2023).","DOI":"10.1016\/j.ymthe.2023.05.005"},{"key":"40476_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nbt.3081","volume":"33","author":"JA Zuris","year":"2015","unstructured":"Zuris, J. A. et al. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat. Biotechnol. 33, 73\u201380 (2015).","journal-title":"Nat. Biotechnol."},{"key":"40476_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nbt.3471","volume":"34","author":"H Yin","year":"2016","unstructured":"Yin, H. et al. Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo. Nat. Biotechnol. 34, 328\u2013333 (2016).","journal-title":"Nat. Biotechnol."},{"key":"40476_CR11","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nbt.3469","volume":"34","author":"Y Yang","year":"2016","unstructured":"Yang, Y. et al. A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice. Nat. Biotechnol. 34, 334\u2013338 (2016).","journal-title":"Nat. Biotechnol."},{"key":"40476_CR12","doi-asserted-by":"publisher","unstructured":"Amoasii, L. et al. Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy. Sci. Transl. Med. 9, https:\/\/doi.org\/10.1126\/scitranslmed.aan8081 (2017).","DOI":"10.1126\/scitranslmed.aan8081"},{"key":"40476_CR13","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1101\/gr.171322.113","volume":"24","author":"S Kim","year":"2014","unstructured":"Kim, S., Kim, D., Cho, S. W., Kim, J. & Kim, J. S. Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res. 24, 1012\u20131019 (2014).","journal-title":"Genome Res."},{"key":"40476_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature25164","volume":"553","author":"X Gao","year":"2018","unstructured":"Gao, X. et al. Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents. Nature 553, 217\u2013221 (2018).","journal-title":"Nature"},{"key":"40476_CR15","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s41591-019-0500-9","volume":"25","author":"B Gy\u00f6rgy","year":"2019","unstructured":"Gy\u00f6rgy, B. et al. Allele-specific gene editing prevents deafness in a model of dominant progressive hearing loss. Nat. Med. 25, 1123\u20131130 (2019).","journal-title":"Nat. Med."},{"key":"40476_CR16","doi-asserted-by":"publisher","unstructured":"Yeh, W. H. et al. In vivo base editing restores sensory transduction and transiently improves auditory function in a mouse model of recessive deafness. Sci. Transl. Med. 12, https:\/\/doi.org\/10.1126\/scitranslmed.aay9101 (2020).","DOI":"10.1126\/scitranslmed.aay9101"},{"key":"40476_CR17","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1056\/NEJMra050700","volume":"354","author":"CC Morton","year":"2006","unstructured":"Morton, C. C. & Nance, W. E. Newborn hearing screening-a silent revolution. N. Engl. J. Med. 354, 2151\u20132164 (2006).","journal-title":"N. Engl. J. Med."},{"key":"40476_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00439-018-1965-1","volume":"138","author":"JJ Smits","year":"2019","unstructured":"Smits, J. J. et al. De novo and inherited loss-of-function variants of ATP2B2 are associated with rapidly progressive hearing impairment. Hum. Genet. 138, 61\u201372 (2019).","journal-title":"Hum. Genet."},{"key":"40476_CR19","doi-asserted-by":"publisher","first-page":"5066","DOI":"10.1523\/JNEUROSCI.21-14-05066.2001","volume":"21","author":"RA Dumont","year":"2001","unstructured":"Dumont, R. A. et al. Plasma membrane Ca2+-ATPase isoform 2a is the PMCA of hair bundles. J. Neurosci. 21, 5066\u20135078 (2001).","journal-title":"J. Neurosci."},{"key":"40476_CR20","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJMoa043899","volume":"352","author":"JM Schultz","year":"2005","unstructured":"Schultz, J. M. et al. Modification of human hearing loss by plasma-membrane calcium pump PMCA2. N. Engl. J. Med. 352, 1557\u20131564 (2005).","journal-title":"N. Engl. J. Med."},{"key":"40476_CR21","doi-asserted-by":"publisher","first-page":"e1000238","DOI":"10.1371\/journal.pgen.1000238","volume":"4","author":"SL Spiden","year":"2008","unstructured":"Spiden, S. L. et al. The novel mouse mutation Oblivion inactivates the PMCA2 pump and causes progressive hearing loss. PLoS Genet. 4, e1000238 (2008).","journal-title":"PLoS Genet."},{"key":"40476_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/01.GIM.0000078026.01140.68","volume":"5","author":"A Pandya","year":"2003","unstructured":"Pandya, A. et al. Frequency and distribution of GJB2 (connexin 26) and GJB6 (connexin 30) mutations in a large North American repository of deaf probands. Genet. Med. 5, 295\u2013303 (2003).","journal-title":"Genet. Med."},{"key":"40476_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00439-008-0602-9","volume":"125","author":"XZ Liu","year":"2009","unstructured":"Liu, X. Z. et al. Digenic inheritance of non-syndromic deafness caused by mutations at the gap junction proteins Cx26 and Cx31. Hum. Genet. 125, 53\u201362 (2009).","journal-title":"Hum. Genet."},{"key":"40476_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15198-9","volume":"11","author":"M Li","year":"2020","unstructured":"Li, M. et al. Digenic inheritance of mutations in EPHA2 and SLC26A4 in Pendred syndrome. Nat. Commun. 11, 1343 (2020).","journal-title":"Nat. Commun."},{"key":"40476_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/hmg\/ddi010","volume":"14","author":"QY Zheng","year":"2005","unstructured":"Zheng, Q. Y. et al. Digenic inheritance of deafness caused by mutations in genes encoding cadherin 23 and protocadherin 15 in mice and humans. Hum. Mol. Genet. 14, 103\u2013111 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"40476_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1006\/cbir.1998.0339","volume":"23","author":"F Kalinec","year":"1999","unstructured":"Kalinec, F., Kalinec, G., Boukhvalova, M. & Kachar, B. Establishment and characterization of conditionally immortalized organ of corti cell lines. Cell Biol. Int. 23, 175\u2013184 (1999).","journal-title":"Cell Biol. Int."},{"key":"40476_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nbt.3117","volume":"33","author":"SQ Tsai","year":"2015","unstructured":"Tsai, S. Q. et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat. Biotechnol. 33, 187\u2013197 (2015).","journal-title":"Nat. Biotechnol."},{"key":"40476_CR28","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.cell.2017.04.005","volume":"169","author":"AC Komor","year":"2017","unstructured":"Komor, A. C., Badran, A. H. & Liu, D. R. CRISPR-based technologies for the manipulation of eukaryotic genomes. Cell 169, 559 (2017).","journal-title":"Cell"},{"key":"40476_CR29","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."},{"key":"40476_CR30","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.4192","volume":"36","author":"M Kosicki","year":"2018","unstructured":"Kosicki, M., Tomberg, K. & Bradley, A. Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements. Nat. Biotechnol. 36, 765\u2013771 (2018).","journal-title":"Nat. Biotechnol."},{"key":"40476_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/bs.ircmb.2017.01.002","volume":"332","author":"T Cal\u00ec","year":"2017","unstructured":"Cal\u00ec, T., Brini, M. & Carafoli, E. Regulation of cell calcium and role of plasma membrane calcium ATPases. Int. Rev. Cell Mol. Biol. 332, 259\u2013296 (2017).","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"40476_CR32","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.ajhg.2019.09.003","volume":"105","author":"P Dai","year":"2019","unstructured":"Dai, P. et al. Concurrent hearing and genetic screening of 180,469 neonates with follow-up in Beijing, China. Am. J. Hum. Genet. 105, 803\u2013812 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"40476_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijporl.2012.10.015","volume":"77","author":"D Kooshavar","year":"2013","unstructured":"Kooshavar, D. et al. Digenic inheritance in autosomal recessive non-syndromic hearing loss cases carrying GJB2 heterozygote mutations: assessment of GJB4, GJA1, and GJC3. Int. J. Pediatr. Otorhinolaryngol. 77, 189\u2013193 (2013).","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"40476_CR34","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1113\/JP279189","volume":"599","author":"MA Rutherford","year":"2021","unstructured":"Rutherford, M. A., von Gersdorff, H. & Goutman, J. D. Encoding sound in the cochlea: from receptor potential to afferent discharge. J. Physiol. 599, 2527\u20132557 (2021).","journal-title":"J. Physiol."},{"key":"40476_CR35","doi-asserted-by":"publisher","unstructured":"Petit, C., Bonnet, C. & Safieddine, S. Deafness: from genetic architecture to gene therapy. Nat. Rev. Genet, https:\/\/doi.org\/10.1038\/s41576-023-00597-7 (2023).","DOI":"10.1038\/s41576-023-00597-7"},{"key":"40476_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/mt.2015.150","volume":"24","author":"WW Chien","year":"2016","unstructured":"Chien, W. W. et al. Gene therapy restores hair cell stereocilia morphology in inner ears of deaf whirler mice. Mol. Ther. 24, 17\u201325 (2016).","journal-title":"Mol. Ther."},{"key":"40476_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09006-2","volume":"10","author":"G Cullot","year":"2019","unstructured":"Cullot, G. et al. CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations. Nat. Commun. 10, 1136 (2019).","journal-title":"Nat. Commun."},{"key":"40476_CR38","doi-asserted-by":"publisher","unstructured":"Korablev, A., Lukyanchikova, V., Serova, I. & Battulin, N. On-target CRISPR\/Cas9 activity can cause undesigned large deletion in mouse zygotes. Int. J. Mol. Sci. 21, https:\/\/doi.org\/10.3390\/ijms21103604 (2020).","DOI":"10.3390\/ijms21103604"},{"key":"40476_CR39","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nbt.2909","volume":"32","author":"JP Guilinger","year":"2014","unstructured":"Guilinger, J. P., Thompson, D. B. & Liu, D. R. Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nat. Biotechnol. 32, 577\u2013582 (2014).","journal-title":"Nat. Biotechnol."},{"key":"40476_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08841-7","volume":"10","author":"W Zhu","year":"2019","unstructured":"Zhu, W. et al. Precisely controlling endogenous protein dosage in hPSCs and derivatives to model FOXG1 syndrome. Nat. Commun. 10, 928 (2019).","journal-title":"Nat. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40476-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40476-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40476-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T18:09:30Z","timestamp":1700244570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-40476-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["40476"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-40476-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1836399\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,15]]},"assertion":[{"value":"7 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Z.-Y.C. is a cofounder of Salubritas Therapeutics. He and D.R.L. have filed patent applications on: Efficient delivery of therapeutic molecules in vitro and in vivo\u201d (15\/523325) and \u201cMethod for efficient delivery of therapeutic molecules in vitro and in vivo\u201d (15\/523321). B.P.K. is an inventor on patents and patent applications filed by Mass General Brigham that describe genome engineering technologies. B.P.K. is a consultant for Avectas Inc., EcoR1 capital, and ElevateBio, and is an advisor to Acrigen Biosciences and Life Edit Therapeutics. X.L. is a SAB member of Rescue Hearing Inc, and a SAB member of Salubritas Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4928"}}